- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 7.92M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.76M |
| Current Liabilities restated | Q1 2025 · Dec 31, 2024 | $6.89M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.92M |
| Total Liabilities restated | Q1 2025 · Dec 31, 2024 | $9.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $9.82M |
| Current Assets restated | Q1 2025 · Dec 31, 2024 | $9.6M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.16M |
| Total Assets restated | Q1 2025 · Dec 31, 2024 | $27.35M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 7.44M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $56.44K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$94.89K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $2.77M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $2.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $19.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $19.42M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $750.58K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.21M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$557.42K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$485.18K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.5M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.47M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.98M |